{
    "Case ID": "068677",
    "Crime_Name": [
        "Patent Infringement Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent Infringement Dispute"
    ],
    "Legal_Issue": [
        "Whether the Minister should be prohibited from issuing Notices of Compliance to generic drug manufacturers until the patent for escitalopram expires"
    ],
    "Governing_Law": [
        "Patented Medicine (Notice of Compliance) Regulations"
    ],
    "Procedural_Stage": [
        "Application under PM(NOC) Regulations"
    ],
    "Evidence_Assessment": [
        "Resolving citalopram into enantiomers was non-obvious and inventive; no prior art disclosed escitalopram's utility"
    ],
    "Decision_Outcome": [
        "Prohibition orders issued"
    ],
    "Burden_of_Proof": [
        "Patent holder must prove allegations of invalidity are not justified"
    ],
    "Credibility_Factor": [],
    "Legal_Rule": [
        "If a patent holder proves that allegations of invalidity are not justified, the Minister cannot authorize generic versions until the patent expires"
    ],
    "Standard_of_Review": [],
    "Procedural_Issue": [],
    "Grounds_for_Claim": [
        "Anticipation, obviousness, selection patent"
    ],
    "Outcome_on_Merits": [
        "Lundbeck proved allegations of invalidity were not justified"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [],
    "Review_Standard": [],
    "Procedural_Fairness_Assessment": [],
    "Key_Evidence_Considered": [
        "Non-obviousness of enantiomer resolution, lack of prior art disclosing escitalopram"
    ],
    "Legal_Framework": [
        "PM(NOC) Regulations"
    ],
    "Applicant_Challenge": [
        "Lundbeck filed applications seeking prohibition orders against three generic manufacturers"
    ],
    "Court_Result": [
        "Prohibition orders granted"
    ],
    "Legal_Rule_Source": [
        "Patented Medicine (Notice of Compliance) Regulations"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Generic manufacturers alleged the patent was invalid"
    ],
    "Evidence_Type": [
        "Scientific evidence, prior art analysis"
    ],
    "Remedy_Requested": [
        "Prohibition of Notices of Compliance"
    ],
    "Outcome": [
        "Minister prohibited from issuing Notices of Compliance until 2014"
    ],
    "Decision_Authority": [
        "Federal Court"
    ],
    "Remedy_Sought": [
        "Injunction preventing regulatory approval of generics"
    ],
    "Resolution_Mechanism": [
        "Judicial determination under PM(NOC) framework"
    ],
    "Legal_Provision": [
        "Patented Medicine (Notice of Compliance) Regulations"
    ],
    "Authority": [
        "Minister of Health"
    ],
    "Claimant_Status": [
        "Patent holder (Lundbeck)"
    ],
    "Legal_Provision_Cited": [
        "Patented Medicine (Notice of Compliance) Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Patent invalidity based on anticipation and obviousness"
    ],
    "Applicable_Process": [
        "PM(NOC) application process"
    ],
    "Outcome_of_Review": [
        "Successful prohibition"
    ],
    "Pending_Relief_or_Application": [
        "Applications for prohibition orders"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Patented Medicine (Notice of Compliance) Regulations"
    ]
}